How Computer Vision Is Reshaping Non-Invasive Screening

By Henry Duah

Across healthcare, a quiet shift is taking place: cameras are becoming diagnostic tools. From smartphones and portable clinic devices to specialised imaging systems, cameras are increasingly being paired with computer vision and artificial intelligence to detect health risks earlier and more conveniently. Instead of simply capturing images for documentation, these systems analyse visual data to identify patterns linked to disease. The result is a new generation of screening tools that can flag potential conditions without needles, laboratory tests, or highly specialised imaging suites.

This approach is particularly powerful for screening and triage. By analysing images of the body, whether retinal scans, cervical images, or thermal patterns, AI models can help clinicians determine who may need further testing and who can safely remain in routine care.

The broader trend is what some experts describe as “non-invasive triage”: using computer vision and AI to expand access to early screening while reducing the burden on specialists.

Several companies are pioneering technologies that demonstrate how cameras can become a first line of detection. Rather than replacing traditional diagnostics, these tools are increasingly acting as the first layer of screening, helping health systems identify risk earlier, prioritise referrals, and reach more patients.

Niramai: Thermal Imaging + AI (Breast Screening)

Niramai has developed an AI-driven breast cancer screening solution called Thermalytix that uses thermal imaging combined with machine learning algorithms to analyse heat patterns on the breast surface. Because abnormal tissue activity can influence blood flow and temperature distribution, thermal imaging can reveal subtle physiological signals that may be difficult for the human eye to interpret.

Thermalytix processes these thermal scans using AI models to generate a quantitative risk report that helps clinicians identify potentially abnormal patterns associated with breast health. What makes Niramai’s approach distinctive is its focus on accessibility. The screening process is non-contact, radiation-free, and designed to be more comfortable than traditional mammography. This makes it particularly appealing for outreach programmes and settings where screening infrastructure is limited or where women may avoid screening due to discomfort or cost barriers.

Digital Diagnostics: Autonomous AI + Retinal Imaging (Diabetic Retinopathy Screening)

Diabetic retinopathy is one of the leading causes of preventable blindness globally, yet screening rates remain low in many regions due to shortages of eye specialists. LumineticsCore, developed by Digital Diagnostics, addresses this challenge by combining retinal imaging with autonomous AI. The system analyses retinal photographs taken with a specialised camera and can independently determine whether signs of diabetic retinopathy are present.
What makes this system notable is that it is designed to function without a specialist interpreting the results. Once images are captured, the AI system automatically analyses them and produces a diagnostic output, enabling screening to occur directly in primary care settings. This approach allows clinics to screen significantly more patients while ensuring that ophthalmologists focus their time on patients who truly need advanced care.

Liger Medical: EVA System + Automated Visual Evaluation (Cervical Cancer Screening Decision Support)

Cervical cancer screening in many low-resource settings relies on Visual Inspection with Acetic Acid (VIA), a method that can be effective but often depends heavily on clinician experience. Liger Medical developed the EVA System, a portable digital colposcope that captures high-resolution images of the cervix. These images can then be analysed using Automated Visual Evaluation (AVE), an AI-driven algorithm that assists clinicians in identifying precancerous lesions.

By combining imaging hardware with AI analysis, the solution helps standardise interpretation and improve screening accuracy. This is particularly valuable in settings where specialist training is limited and diagnostic consistency can vary.

Get innovation insights from The FutureList weekly. Subscribe to our newsletter here